New Millennium Group’s Eli Lilly LLY Stock Holding History

New Millennium Group’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$117K	Sell	109 -6	-5%	-$5.74K	0.05%	92
2025 Q3	$88.1K	Sell	115 -1,940	-94%	-$1.44M	0.04%	84
2025 Q2	$1.6M	Buy	2,055 +355	+21%	+$276K	0.89%	31
2025 Q1	$1.4M	Buy	1,700 +1,562	+1,132%	+$1.3M	0.92%	23
2024 Q4	$106K	Sell	138 -60	-30%	-$49.7K	0.06%	68
2024 Q3	$175K	Sell	198 -4	-2%	-$3.6K	0.11%	56
2024 Q2	$183K	Buy	+202	New	+$162K	0.12%	61
2024 Q1	–	Sell	-192	Closed	-$112K	–	255
2023 Q4	$112K	Buy	192 +70	+57%	+$40.9K	0.1%	71
2023 Q3	$65.5K	Hold	122	–	–	0.06%	67
2023 Q2	$57.1K	Buy	122 +1	+0.8%	+$419	0.05%	81
2023 Q1	$41.7K	Buy	121 +15	+14%	+$5.06K	0.04%	111
2022 Q4	$38.8K	Hold	106	–	–	0.04%	108
2022 Q3	$34K	Buy	106 +1	+1%	+$317	0.04%	111
2022 Q2	$34K	Buy	+105	New	+$31.5K	0.03%	115

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

New Millennium Group's LLY Position: Q4 2025 in Review

New Millennium Group reduced its Eli Lilly (LLY) stake by 5.2% in Q4 2025, selling an estimated $5.74K and leaving 109 shares worth $117K. The position accounts for 0.05% of the portfolio, ranked #92.

New Millennium Group first reported a position in LLY in Q2 2022 and has held it in 14 quarters since. The position peaked at $1.6M in Q2 2025. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

New Millennium Group held 109 shares of Eli Lilly worth $117K as of Q4 2025.
New Millennium Group sold 6 Eli Lilly shares in Q4 2025, an estimated $5.74K.
Eli Lilly made up 0.05% of New Millennium Group's portfolio in Q4 2025, its #92 holding.
New Millennium Group first reported a position in Eli Lilly in Q2 2022 and has held it in 14 quarters since.
New Millennium Group's Eli Lilly position peaked at $1.6M in Q2 2025.
4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on New Millennium Group's 13F filing for Q4 2025, filed 6 Feb 2026.